Explore more publications!

Press Releases

Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management
ESO Launches Logis Dispatch PrepIQ, Enabling Risk-Free Training for Emergency Communications Centers and Health Systems to Improve Performance and Outcomes
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors
Digital Therapeutics Set to Surge to Historic Heights by 2036 Across Multiple Segments – Towards Healthcare Research and Consulting
Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase 3 trial
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
SEO Dubai Experts Launched by Digital Gravity to Meet Rising SEO & GEO Demand in UAE
Head-On Train Crash in Denmark Injures Multiple People, Some Critically

Head-On Train Crash in Denmark Injures Multiple People, Some Critically

VISTAJET UNVEILS SUMMER PRIVATE WORLD COLLECTION 2026: IMMERSIVE JOURNEYS AT THE EDGE OF THE EXTRAORDINARY
Several Wounded in Denmark Head-On Train Crash

Several Wounded in Denmark Head-On Train Crash

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
WHO: AI Adoption Spreads Rapidly Across EU Healthcare

WHO: AI Adoption Spreads Rapidly Across EU Healthcare

Focus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environment
Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq
New Research Shows Shared Roots of Major Degenerative Diseases
Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Amarin Reports 2026 First Quarter Financial Results
Health Experts Highlight 7 Reasons Seniors Should Stay Active

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions